Glaxosmithkline Plc Adr Stock Retained Earnings

GSK Stock  USD 43.13  0.14  0.33%   
GlaxoSmithKline PLC ADR fundamentals help investors to digest information that contributes to GlaxoSmithKline PLC's financial success or failures. It also enables traders to predict the movement of GlaxoSmithKline Stock. The fundamental analysis module provides a way to measure GlaxoSmithKline PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GlaxoSmithKline PLC stock.
Retained Earnings is expected to rise to about 7.6 B this year.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

GlaxoSmithKline Retained Earnings Analysis

GlaxoSmithKline PLC's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

GlaxoSmithKline PLC Retained Earnings

7.6 Billion

Retained Earnings

 = 

Beginning RE + Income

-

Dividends

More About Retained Earnings | All Equity Analysis

Current GlaxoSmithKline PLC Retained Earnings

    
  7.24 B  
Most of GlaxoSmithKline PLC's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GlaxoSmithKline PLC ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

GlaxoSmithKline Retained Earnings Driver Correlations

Understanding the fundamental principles of building solid financial models for GlaxoSmithKline PLC is extremely important. It helps to project a fair market value of GlaxoSmithKline Stock properly, considering its historical fundamentals such as Retained Earnings. Since GlaxoSmithKline PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GlaxoSmithKline PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GlaxoSmithKline PLC's interrelated accounts and indicators.
-0.320.50.90.77-0.070.770.970.910.710.70.120.940.120.50.95-0.11-0.160.230.450.56-0.260.57-0.590.590.40.490.5-0.250.2
-0.320.29-0.36-0.590.31-0.3-0.36-0.06-0.380.220.26-0.420.170.11-0.29-0.150.06-0.57-0.03-0.25-0.020.030.11-0.110.26-0.130.050.52-0.7
0.50.290.430.10.390.040.310.480.250.330.880.51-0.10.380.68-0.65-0.230.10.520.690.060.75-0.270.780.70.420.820.35-0.44
0.9-0.360.430.7-0.090.740.890.820.90.650.080.82-0.080.640.84-0.020.020.20.380.5-0.050.47-0.490.650.320.580.5-0.260.24
0.77-0.590.10.7-0.10.780.820.670.590.53-0.230.740.00.350.690.22-0.060.310.260.39-0.150.39-0.510.270.080.130.24-0.220.37
-0.070.310.39-0.09-0.1-0.22-0.090.13-0.090.00.42-0.18-0.14-0.240.03-0.06-0.510.180.580.390.210.54-0.270.110.67-0.190.610.39-0.51
0.77-0.30.040.740.78-0.220.850.80.590.78-0.40.640.290.630.590.410.17-0.130.050.04-0.350.12-0.520.12-0.050.10.06-0.30.38
0.97-0.360.310.890.82-0.090.850.910.750.74-0.110.880.140.470.860.08-0.150.230.410.45-0.270.48-0.630.460.330.420.4-0.290.25
0.91-0.060.480.820.670.130.80.910.650.880.060.720.140.60.790.14-0.04-0.040.440.4-0.20.48-0.540.410.410.310.47-0.210.13
0.71-0.380.250.90.59-0.090.590.750.650.55-0.030.65-0.250.560.660.120.120.250.310.420.140.34-0.310.550.190.530.37-0.180.21
0.70.220.330.650.530.00.780.740.880.55-0.140.490.150.740.550.280.23-0.330.210.1-0.160.25-0.40.180.210.140.21-0.01-0.02
0.120.260.880.08-0.230.42-0.4-0.110.06-0.03-0.140.2-0.220.030.37-0.78-0.290.180.430.630.20.60.020.660.60.320.70.34-0.44
0.94-0.420.510.820.74-0.180.640.880.720.650.490.20.140.380.96-0.33-0.260.40.370.61-0.310.61-0.570.70.350.570.51-0.130.14
0.120.17-0.1-0.080.0-0.140.290.140.14-0.250.15-0.220.14-0.110.020.15-0.29-0.35-0.39-0.45-0.98-0.13-0.17-0.14-0.18-0.09-0.18-0.040.06
0.50.110.380.640.35-0.240.630.470.60.560.740.030.38-0.110.440.130.65-0.46-0.10.020.10.03-0.060.29-0.080.250.12-0.040.13
0.95-0.290.680.840.690.030.590.860.790.660.550.370.960.020.44-0.38-0.260.360.510.73-0.170.73-0.580.760.520.560.67-0.050.03
-0.11-0.15-0.65-0.020.22-0.060.410.080.140.120.28-0.78-0.330.150.13-0.380.38-0.4-0.32-0.59-0.07-0.580.14-0.66-0.53-0.49-0.52-0.370.49
-0.160.06-0.230.02-0.06-0.510.17-0.15-0.040.120.23-0.29-0.26-0.290.65-0.260.38-0.65-0.54-0.460.35-0.640.54-0.34-0.65-0.17-0.56-0.250.39
0.23-0.570.10.20.310.18-0.130.23-0.040.25-0.330.180.4-0.35-0.460.36-0.4-0.650.570.70.210.57-0.420.460.450.350.490.09-0.12
0.45-0.030.520.380.260.580.050.410.440.310.210.430.37-0.39-0.10.51-0.32-0.540.570.840.340.75-0.540.430.870.150.720.07-0.31
0.56-0.250.690.50.390.390.040.450.40.420.10.630.61-0.450.020.73-0.59-0.460.70.840.330.85-0.410.720.770.40.810.11-0.23
-0.26-0.020.06-0.05-0.150.21-0.35-0.27-0.20.14-0.160.2-0.31-0.980.1-0.17-0.070.350.210.340.330.040.240.010.15-0.040.120.1-0.13
0.570.030.750.470.390.540.120.480.480.340.250.60.61-0.130.030.73-0.58-0.640.570.750.850.04-0.650.760.880.450.920.41-0.52
-0.590.11-0.27-0.49-0.51-0.27-0.52-0.63-0.54-0.31-0.40.02-0.57-0.17-0.06-0.580.140.54-0.42-0.54-0.410.24-0.65-0.4-0.56-0.25-0.53-0.160.24
0.59-0.110.780.650.270.110.120.460.410.550.180.660.7-0.140.290.76-0.66-0.340.460.430.720.010.76-0.40.60.810.830.25-0.29
0.40.260.70.320.080.67-0.050.330.410.190.210.60.35-0.18-0.080.52-0.53-0.650.450.870.770.150.88-0.560.60.360.870.31-0.59
0.49-0.130.420.580.13-0.190.10.420.310.530.140.320.57-0.090.250.56-0.49-0.170.350.150.4-0.040.45-0.250.810.360.52-0.01-0.1
0.50.050.820.50.240.610.060.40.470.370.210.70.51-0.180.120.67-0.52-0.560.490.720.810.120.92-0.530.830.870.520.36-0.47
-0.250.520.35-0.26-0.220.39-0.3-0.29-0.21-0.18-0.010.34-0.13-0.04-0.04-0.05-0.37-0.250.090.070.110.10.41-0.160.250.31-0.010.36-0.9
0.2-0.7-0.440.240.37-0.510.380.250.130.21-0.02-0.440.140.060.130.030.490.39-0.12-0.31-0.23-0.13-0.520.24-0.29-0.59-0.1-0.47-0.9
Click cells to compare fundamentals
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Competition

Based on the latest financial disclosure, GlaxoSmithKline PLC ADR has a Retained Earnings of 7.24 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The retained earnings for all United States stocks is 22.41% higher than that of the company.

GlaxoSmithKline Retained Earnings Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GlaxoSmithKline PLC's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GlaxoSmithKline PLC could also be used in its relative valuation, which is a method of valuing GlaxoSmithKline PLC by comparing valuation metrics of similar companies.
GlaxoSmithKline PLC is currently under evaluation in retained earnings category among related companies.

GlaxoSmithKline Fundamentals

About GlaxoSmithKline PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze GlaxoSmithKline PLC ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GlaxoSmithKline PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GlaxoSmithKline PLC ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Retained Earnings7.2 B7.6 B
Retained Earnings Total Equity 0.00  0.00 

GlaxoSmithKline PLC Investors Sentiment

The influence of GlaxoSmithKline PLC's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in GlaxoSmithKline. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to GlaxoSmithKline PLC's public news can be used to forecast risks associated with an investment in GlaxoSmithKline. The trend in average sentiment can be used to explain how an investor holding GlaxoSmithKline can time the market purely based on public headlines and social activities around GlaxoSmithKline PLC ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
GlaxoSmithKline PLC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for GlaxoSmithKline PLC's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average GlaxoSmithKline PLC's news discussions. The higher the estimated score, the more favorable is the investor's outlook on GlaxoSmithKline PLC.

GlaxoSmithKline PLC Implied Volatility

    
  20.49  
GlaxoSmithKline PLC's implied volatility exposes the market's sentiment of GlaxoSmithKline PLC ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if GlaxoSmithKline PLC's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that GlaxoSmithKline PLC stock will not fluctuate a lot when GlaxoSmithKline PLC's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GlaxoSmithKline PLC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GlaxoSmithKline PLC's short interest history, or implied volatility extrapolated from GlaxoSmithKline PLC options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:
Check out GlaxoSmithKline PLC Piotroski F Score and GlaxoSmithKline PLC Altman Z Score analysis.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
0.58
Earnings Share
3.02
Revenue Per Share
14.97
Quarterly Revenue Growth
0.092
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.